Effect of Flex-a-New on Osteoarthritis of the Knee

Status

UNKNOWN

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00294801

Enrollment

Registered

2006-02-22

Start date

2006-01-31

Completion date

2007-12-31

Last updated

2006-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis

Keywords

knee osteoarthritis

Brief summary

comparative trial of placebo versus flex-a-new (a food supplement) containing glucosamine an chondroitin sulfate for the symptom modification is knee osteoarthritis

Detailed description

comparative trial of placebo versus flex-a-new (a food supplement) containing glucosamine an chondroitin sulfate for the symptom modification is knee osteoarthritis

Interventions

DRUGflex-a-new (food supplement)

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE

Eligibility

Sex/Gender

ALL

Age

18 Years to 85 Years

Healthy volunteers

Inclusion criteria

knee osteoarthritis grade 1 to 3 -

Exclusion criteria

ischemic heart disease with CHF -

Design outcomes

Primary

Measure	Time frame
KOOS	—

Secondary

Measure	Time frame
VAS KSS	—

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026